期刊文献+

帕金森病模型大鼠行为学评价与黑质神经元凋亡的相关研究 被引量:9

Behavior and Neuronal Apoptosis in Substantia Nigra of Rats with Parkinson's Disease
下载PDF
导出
摘要 目的检测帕金森病(PD)模型大鼠行为学及黑质神经元凋亡的相关指标。方法将6-羟基多巴胺(6-OHDA)通过立体定位仪注入大鼠右侧纹状体制备PD模型,5周后检测行为学指标;酪氨酸羟化酶(TH)组化染色观察各组大鼠右侧黑质神经元形态,Hoechst33258染色了解其凋亡情况,Western blotting方法检测黑质内caspase-3蛋白表达。结果成功筛选的15只PD模型大鼠在露台Morris水迷宫实验中,与正常对照组及假手术组同侧相比,其寻台速度下降,时间延长(P<0.05);在平衡杆实验中,其潜伏期和过杆时间增加(P<0.05);模型组右侧黑质TH阳性神经元明显减少,该区域凋亡细胞明显增多,且caspase-3蛋白表达显著增高。结论6-OHDA诱导黑质内多巴胺(DA)神经元凋亡与其胞内caspase-3表达增高相关,模型大鼠在露台Morris水迷宫和平衡杆实验中行为学改变与TH免疫组化染色及Hoechst33258染色结果吻合。 Objective To assess rat behavior,observe apoptotic morphology of neurons and measure expression of caspase-3 in substantia nigra(SN) of Parkinson's disease(PD) animal model. Methods 6-OHDA was stereotacticly injected into the right striatum of the rats at two sites to produce PD models. After 5 weeks,the behavior tests including modified Morris Water Maze and narrow beam test were measured. Then tyrosine hydroxylase (TH) histochemistry,Hoechst 33258 staining,Western blotting for caspase-3 in right substantia nigra was separately conducted.Results Escape velocity significantly decreased and its latency was obviously enlarged in modified Morris Water Maze,and the latency and total time in narrow beam test were also markedly increased (P〈0.05) in 15 successful PD rats compared with either the sham group or the normal group. Furthermore,there were obvious less TH-positive neurons in lesioned SN while more apoptotic cells appeared there. In addition,the expression of caspase-3 was highly upregulated in lesioned SN.Conclusion 6-OHDA induced neuronal apoptosis in SN is associated with high levels of caspase-3,and the results of rat behavior tests are correspondent with the morphological changes including TH immunohistochemistry and Hoechst 33258 staining. Thus modified Morris Water Maze and narrow beam test are beneficial for assessments of effects of new drugs in PD animal model.
出处 《中国康复理论与实践》 CSCD 2010年第4期301-304,I0001,共5页 Chinese Journal of Rehabilitation Theory and Practice
基金 国家863基金项目(2006AA02A408) 科技部重大新药创制科技专项项目(2009ZX09303)
关键词 帕金森病 6-羟基多巴胺 黑质 行为学 凋亡 Parkinson's disease (PD) 6-hydroxydopamine substantia nigra behavior apoptosis
  • 相关文献

参考文献16

  • 1Halbach OVBU.Modeling neurodegenerative diseases in vivo review[J].Neurodegener Dis,2005,2(6):313-320.
  • 2Deumens R,Blokland A,Prickaerts J.Modeling Parkinson's disease in rats:an evaluation of 6-OHDA lesions of the nigrostriatal pathway[J].Exp Neurol,2002,175:303-317.
  • 3Whishaw IQ,Dunnett SB.Dopamine depletion,stimulation or blockade in the rat disrupts spatial navigation and locomotion dependent upon beacon or distal cues[J].Behav Brain Res,1985,18:11-29.
  • 4Allbutt HN,Henderson JM.Use of the narrow beam test in the rat,6-hydroxydopamine model of Parkinson's disease[J].J Neurosci Methods,2007,159:195-202.
  • 5Lee CS,Sauer H,Bjorklund A.Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat[J].Neuroscience,1996,72:641-653.
  • 6王涛,左萍萍.帕金森病实验动物模型研究进展[J].中国神经免疫学和神经病学杂志,2008,15(6):455-457. 被引量:11
  • 7Ji C,Aisa HA,Yang N,et al.Gossypium herbaceam extracts inhibited NF-kappaB activation to attenuate spatial memory impairment and hippocampal neurodegeneration induced by amyloid-beta in rats[J].J Alzheimers Dis,2008,14:271-283.
  • 8Glinka Y,Gassen M,Youdim MB.Mechanism of 6-hydroxydopamine neurotoxicity[J].J Neural Transm Suppl,1997,50:55-66.
  • 9Green DR,Reed JC.Mitochondria and apoptosis[J].Science,1998,281:1309-1312.
  • 10Hartmann A,Hunot S,Michel PP,et al.Caspase-3:A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease[J].Proc Natl Acad Sci USA,2000,97:2875-2880.

二级参考文献10

  • 1Hallett PJ, Brotchie JM. Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia[J]. Mov Disord, 2007,22 (1): 28-40.
  • 2Emborg ME. Evaluation of animal models of Parkinson's disease for neuroprotective strategies [J]. J Neurosci Methods, 2004,139 (2):121-143.
  • 3Reksidler AB, Lima MM, Zanata SM, et al. The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats[J]. Eur J Pharmacol,2007,560(2-3):163-175.
  • 4Richardson JR, Quan Y, Sherer TB,et al. Paraquat neurotoxicity is distinct from that of MPTP and rote none[J]. Toxicol Sci, 2005, 8(1) :193-201.
  • 5Li X, Matsumoto K, Murakami Y,et al. Neuroprotective effects of Polygonum muhiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice[J]. Pharmacol Biochem Behav, 2005, 82(2):345-352.
  • 6Hunter RL, Dragicevic N, Seifert K,et al. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system[J]. J Neurochem, 2007,100(5) : 1375-1386.
  • 7Goldberg MS, Fleming SM, Palacino JJ,et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons[J]. J Biol Chem, 2003, 278(44) :43628-43635.
  • 8Kim RH, Smith PD, Aleyasin H,et al. Hypersensitivity of DJ-1-defieient mice to 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyrindine (MPTP) and oxidative stress [J]. Proc Natl Acad Sci U S A, 2005, 102(14) :5215- 5220.
  • 9Battaglia G, Farrace MG, Mastroberardino PG,et al. Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex Ⅰ affecting neuronal vulnerability in experimental models of extrapyramidal disorders [J]. J Neurochem, 2007, 100 (1) : 36- 49.
  • 10McNaught KS, PerI DP, Brownell AL, et al. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease[J]. Ann Neurol, 2004,56(1) :149-162.

共引文献10

同被引文献79

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部